Phalanx Biotech Group last week launched its Rat Whole Genome OneArray for gene expression profiling.
The chip's content is curated from the RefSeq and Ensembl databases. It includes 25,338 long oligonucleotide probes engineered to meet isothermal requirements for hybridization performance. Phalanx claims the chip offers "high correlation" with quantitative PCR. The Taiwanese firm added that the array enables the interrogation of pathways observed in rat disease models and animal drug metabolism and pharmacokinetics studies.
Skyline Diagnostics last week launched its AMLprofiler for clinical use in Europe.
The test, which runs on the Affymetrix GeneChip platform, allows users to classify individual acute myeloid leukemia patients into different risk categories. Within four days, AMLprofiler can identify AML subtypes in order to help clinicians select the appropriate method of treatment, Skyline said.
BioArray News spoke with Skyline officials about the test last week (BAN 3/15/2011).